IDIS Managed Access

Idis Managed Access (MA) is the global leader in the management of ethical worldwide access to the most promising, innovative early stage medicines on behalf of pharmaceutical and biotech companies, to address unmet patient need.

IDIS Managed Access
Who we are

We are the global leaders in the strategic planning, implementation and execution of global Managed Access Programs, enabling pharma and biotech companies to provide early access to treatments for patients with unmet needs.


Our team consists of some of the leading industry experts in Early Access with real life experience of the delivery of early access on a global basis outside the clinical environment.

Clinigen Consulting

Clinigen Consulting is an integrated strategic arm working across all of our service offerings, bringing together over 30 years of insight and expertise.Maximize the value of your Managed Access Program for all stakeholders.

Early Access Throughout the Product Lifecycle

For over 30 years we have provided ethical, compliant and effective patient access solutions for hundreds of programs, providing access to hundreds of thousands of patients, in 130 countries, across nearly every therapeutic category. 

Get In Touch

Contact us for expert information, advice, consultation or quotes.